Sharps Technology, Inc.
$1.84
▼
-7.36%
2026-04-21 09:39:00
sharpstechnology.com
NCM: STSS
Explore Sharps Technology, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$73.85 M
Current Price
$1.84
52W High / Low
$18.23 / $1.42
Stock P/E
—
Book Value
$15.68
Dividend Yield
—
ROCE
-452.36%
ROE
-2.03%
Face Value
—
EPS
$-10.68
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
—
Beta
2.07
Debt / Equity
1.17
Current Ratio
4.02
Quick Ratio
3.88
Forward P/E
-11.13
Price / Sales
316.33
Enterprise Value
$57.27 M
EV / EBITDA
-4.35
EV / Revenue
280.58
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Leverage is relatively high.
- Current ratio suggests tighter short-term liquidity.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Hologic, Inc. | NOT FOUND | — | — | — | 9.77% | 10.86% | $76.07 / $51.9 | $23.51 |
| 2. | Precision Optics Corporation, Inc. | $4.44 | — | $47.43 M | — | -40.7% | -73.56% | $6.04 / $3.55 | $1.21 |
| 3. | Nephros, Inc. | $3.07 | 27.37 | $32.68 M | — | 10.54% | 12.71% | $6.42 / $1.64 | $0.96 |
| 4. | ResMed Inc. | $224.49 | 22.19 | $32.69 B | 1.06% | 23.58% | 25.68% | $293.81 / $202 | $43.39 |
| 5. | Stereotaxis, Inc. | $1.98 | — | $192.55 M | — | -73.98% | -1.44% | $3.59 / $1.74 | $0.14 |
| 6. | Baxter International Inc. | $18.8 | — | $9.79 B | 0.21% | 1.04% | -13.71% | $32.68 / $15.73 | $11.92 |
| 7. | Anbio Biotechnology | $26.98 | 380.56 | $3.88 B | — | 11.61% | 27.05% | $55.65 / $6.05 | $0.63 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | -0.1 M | 0.08 M | 0.22 M | 0 M | 0 M | — |
| Operating Profit | 102.38 M | -110.65 M | -3.01 M | -2.02 M | -3.85 M | — |
| Net Profit | -182.66 M | -105.33 M | 3.56 M | 1.93 M | -4.53 M | — |
| EPS in Rs | -4.72 | -2.72 | 0.09 | 0.05 | -0.12 | -379.55 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0.2 M | 0 M | 0 M | 0 M |
| Operating Profit | -13.29 M | -5.57 M | -10.13 M | -8.74 M |
| Net Profit | -282.5 M | -9.3 M | -9.84 M | -4.64 M |
| EPS in Rs | -7.31 | -0.24 | -0.25 | -0.12 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 269.08 M | 7.31 M | 11.79 M | 11.84 M |
| Total Liabilities | 4.7 M | 5.32 M | 3.85 M | 2.2 M |
| Equity | 264.38 M | 2 M | 7.93 M | 9.64 M |
| Current Assets | 18.88 M | 3.17 M | 4.84 M | 4.42 M |
| Current Liabilities | 4.7 M | 5.19 M | 3.69 M | 2.01 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -10.99 M | -4.4 M | -8.51 M | -6.43 M |
| Investing CF | -187.52 M | -1 M | -0.7 M | -3.12 M |
| Financing CF | 215.51 M | 5.91 M | 8.03 M | 12.24 M |
| Free CF | -181.51 M | -4.4 M | -9.21 M | -7.19 M |
| Capex | -170.52 M | -0.14 M | -0.7 M | -0.75 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | — | — | — | — |
| Earnings Growth % | 5.54% | -112.12% | — | — |
| Profit Margin % | — | — | — | — |
| Operating Margin % | — | — | — | — |
| Gross Margin % | — | — | — | — |
| EBITDA Margin % | — | — | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2025-04-28 | 1:0.00333333 |
| 2024-10-16 | 1:0.0454545 |